What's New from the FDA and Why It Matters

The FDA remains a powerful driver of change in pharmacy practice through its approvals, policies, and public health actions. This episode highlights timely FDA developments and emerging areas of focus that pharmacists need to be aware of—from regulatory shifts to new communication initiatives. Tune in to stay informed on FDA activity that could influence the way you practice and care for patients.HOSTJoshua Davis Kinsey, PharmDVP, EducationCEimpactGUESTMary Ross Southworth, PharmDPrincipalS&S Consulting PartnersJoshua Davis Kinsey has no relevant financial relationships to disclose. Mary Ross Southworth is a consultant for Travere, Unicycive, Liquidia, and Mineralys. All relevant financial relationships have been mitigated.  CPE REDEMPTIONThis course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation:If you are already enrolled in this course, click here to redeem your credit. To purchase this episode and claim your CPE credit, click here. CPE INFORMATIONLearning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Recognize current FDA topics and areas of focus relevant to pharmacy practice.2. Describe how current FDA priorities may impact medication use, pharmacist responsibilities, or patient care.0.05 CEU/0.5 HrUAN: 0107-0000-25-296-H03-PInitial release date: 9/22/2025Expiration date: 9/22/2026Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram